Shire extends Medidata trial management contract

- Last updated on GMT

Related tags: Contract research organization

Medidata Solutions has won a multi-year extension to its benchmarking and analysis contract with drugmaker Shire.

The revised multi-year deal, announced late yesterday, adds three new analysis modules to the Medidata Grants Manager and contract research organisation (CRO) Contractor technologies that Shire uses to manage its various clinical programmes.

Medidata said that the expanded analysis capabilities will allow Shire to more closely analyse and control its current and future global clinical trial budgets.

Fred Naids, Shire’s senior strategic sourcing director, said: “We have always benefitted from our collaborative relationship with the Medidata Trial Planning team, and in this case, they were able to help us spot areas for improvements across our budgeting and forecasting process.​”

Moving forward, the Grants Manager and CRO Contractor Analysis modules are going to play a key role in our ability to access and learn from critical benchmarking data​.”

Related news

Show more

Related products

show more

The Essential Clinical Development Resource Center

The Essential Clinical Development Resource Center

Data Management Solution Center | 05-Mar-2020 | Data Sheet

Clinical trials are becoming increasingly complex with oversight workloads increasing too. A recent survey based study conducted by Medidata in association...

Infographic:Transforming Data Capture & Management

Infographic:Transforming Data Capture & Management

Data Management Solution Center | 05-Mar-2020 | Infographic

Is your clinical study's data capture and management processes efficient? Medidata Rave Clinical Cloud is the only industry platform that creates...

Electronic Informed Consent and Global Regulation

Electronic Informed Consent and Global Regulation

Data Management Solution Center | 05-Mar-2020 | Technical / White Paper

Medidata is conducting an on-going study to understand global regulatory positions, adoption and variability regarding eConsent. The benefits of eConsent...

De-risk Go/No Go Product Development Decisions

De-risk Go/No Go Product Development Decisions

Data Management Solution Center | 05-Mar-2020 | Technical / White Paper

Learn how synthetic controls enable new insights for oncology clinical development and mitigates go/no-go decision risk. Synthetic control data can assist...

Related suppliers

Follow us

Products

View more

Webinars